Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Irritable Bowel Syndrome, May 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 110 articles:
HTML format


 

Single Articles

  1. SHEKHAR H, Pradhan
    Probiotics in IBS: A Treatment Boon or a Pill Bulk: RCT-based Analysis.
    J Assoc Physicians India. 2023;71:1.
    PubMed    
    Abstract available

  2. SHAIKH OA, Shaikh G, Aftab RM, Baktashi H, et al
    Unconventional but effective: breaking through IBS-D clinical practice guidelines - correspondence.
    Ann Med Surg (Lond). 2023;85:1312-1313.
    PubMed    
    Abstract available

  3. CHOJNACKI C, Poplawski T, Blonska A, Konrad P, et al
    The Usefulness of the Low-FODMAP Diet with Limited Tryptophan Intake in the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome.
    Nutrients. 2023;15:1837.
    PubMed    
    Abstract available

  4. PITIROLLO O, Grimaldi M, Corradini C, Pironi S, et al
    HPAEC-PAD Analytical Evaluation of Carbohydrates Pattern for the Study of Technological Parameters Effects in Low-FODMAP Food Production.
    Molecules. 2023;28:3564.
    PubMed    
    Abstract available

  5. MAILLARD F, Meynier M, Mondot S, Pepke F, et al
    From In Vitro to In Vivo: A Rational Flowchart for the Selection and Characterization of Candidate Probiotic Strains in Intestinal Disorders.
    Microorganisms. 2023;11:906.
    PubMed    
    Abstract available

  6. NG QX, Yau CE, Yaow CYL, Chong RIH, et al
    What Has Longitudinal 'Omics' Studies Taught Us about Irritable Bowel Syndrome? A Systematic Review.
    Metabolites. 2023;13:484.
    PubMed    
    Abstract available

  7. TRAINI C, Idrizaj E, Biagioni C, Baccari MC, et al
    Otilonium Bromide Prevents Cholinergic Changes in the Distal Colon Induced by Chronic Water Avoidance Stress, a Rat Model of Irritable Bowel Syndrome.
    Int J Mol Sci. 2023;24:7440.
    PubMed    
    Abstract available

  8. LANGLOIS LD, Oddoux S, Auble K, Violette P, et al
    Effects of Glutamine, Curcumin and Fish Bioactive Peptides Alone or in Combination on Intestinal Permeability in a Chronic-Restraint Stress Model.
    Int J Mol Sci. 2023;24:7220.
    PubMed    
    Abstract available

  9. BAWAHAB MA, Bhat MJ, Asiri FNM, Alshahrani KAM, et al
    Assessment of Public's Awareness Regarding Irritable Bowel Syndrome in Aseer Region, Saudi Arabia.
    Healthcare (Basel). 2023;11:1084.
    PubMed    
    Abstract available

  10. HORII K, Sawamura T, Yuki N, Shiina T, et al
    Sex differences in the central regulation of colorectal motility in response to noxious stimuli.
    J Smooth Muscle Res. 2023;59:28-33.
    PubMed    
    Abstract available

  11. FAGHIH DINEVARI M, Jafarzadeh F, Jabbaripour Sarmadian A, Abbasian S, et al
    The effect of melatonin on irritable bowel syndrome patients with and without sleep disorders: a randomized double-blinded placebo-controlled trial study.
    BMC Gastroenterol. 2023;23:135.
    PubMed    
    Abstract available

  12. SAWAMURA T, Yuki N, Horii K, Naitou K, et al
    Essential roles of the hypothalamic A11 region and the medullary raphe nuclei in regulation of colorectal motility in rats.
    Am J Physiol Gastrointest Liver Physiol. 2023.
    PubMed    
    Abstract available

  13. LEE A, Lee JY, Jung SW, Shin SY, et al
    [Brain-Gut-Microbiota Axis].
    Korean J Gastroenterol. 2023;81:145-153.
    PubMed    
    Abstract available

  14. KOO HS, Son HC, Lee HS, Goong HJ, et al
    Survey-Based Analysis of the Clinical Treatment Status of Irritable Bowel Syndrome in Korea.
    J Korean Med Sci. 2023;38:e126.
    PubMed    
    Abstract available

  15. KIM YS
    Current Status of Diagnosis and Treatment of Irritable Bowel Syndrome in Korea.
    J Korean Med Sci. 2023;38:e113.
    PubMed    


  16. SHARMA S, Kumar S, Sajjad S, Sharma S, et al
    Probiotics in Irritable Bowel Syndrome: A Review Article.
    Cureus. 2023;15:e36565.
    PubMed    
    Abstract available

  17. RETTURA F, Lambiase C, Grosso A, Rossi A, et al
    Role of Low-FODMAP diet in functional dyspepsia: "Why", "When", and "to Whom".
    Best Pract Res Clin Gastroenterol. 2023;62-63:101831.
    PubMed    
    Abstract available

  18. COLOMIER E, Algera JP, Van den Houte K, Simren M, et al
    Mechanisms underlying food-related symptoms in disorders of gut-brain interaction: Course ahead in research and clinical practice.
    Best Pract Res Clin Gastroenterol. 2023;62-63:101824.
    PubMed    
    Abstract available

  19. VON DEM KNESEBECK O, Barbek R, Makowski AC
    Social inequalities in aggravating factors of somatic symptom persistence (SOMA.SOC): study protocol for a mixed-method observational study focusing on irritable bowel syndrome and fatigue.
    BMJ Open. 2023;13:e070635.
    PubMed    
    Abstract available

  20. CHUAH KH, Hian WX, Teoh AT, Ling JKY, et al
    Clinical outcome of disorders of gut-brain interaction in secondary care: A longitudinal study.
    Neurogastroenterol Motil. 2023 Apr 24:e14602. doi: 10.1111/nmo.14602.
    PubMed    
    Abstract available

  21. BALASUBRAMANIAM A, Srinivasan S
    Role of stimulator of interferon genes (STING) in the enteric nervous system in health and disease.
    Neurogastroenterol Motil. 2023 Apr 24:e14603. doi: 10.1111/nmo.14603.
    PubMed    
    Abstract available

  22. FUKUDO S, Nakaya K, Muratsubaki T, Nakaya N, et al
    Characteristics of disorders of gut-brain interaction in the Japanese population in the Rome Foundation Global Epidemiological Study.
    Neurogastroenterol Motil. 2023 Apr 24:e14581. doi: 10.1111/nmo.14581.
    PubMed    
    Abstract available

  23. SUN S, Chen J, Li H, Lou Y, et al
    Patients' perspectives on irritable bowel syndrome: a qualitative analysis based on social media in China.
    Qual Life Res. 2023 Apr 24. doi: 10.1007/s11136-023-03417.
    PubMed    
    Abstract available

  24. CASTILLO DF, Denson LA, Haslam DB, Hommel KA, et al
    The microbiome in adolescents with irritable bowel syndrome and changes with percutaneous electrical nerve field stimulation.
    Neurogastroenterol Motil. 2023 Apr 24:e14573. doi: 10.1111/nmo.14573.
    PubMed    
    Abstract available

  25. MENG P, Cheng B, Pan C, Liu L, et al
    Evaluating the role of anxiety on the association between irritable bowel syndrome and brain volumes: a mediation analysis in the UK Biobank cohort.
    Brain Commun. 2023;5:fcad116.
    PubMed    
    Abstract available

  26. IBRAHIM M, Elkins I, Herman M
    Abdominal Migraines: A Rare Adulthood Manifestation of a Typical Childhood Disease.
    Cureus. 2023;15:e36451.
    PubMed    
    Abstract available

  27. ALEMANY S, Soler-Artigas M, Cabana-Dominguez J, Fakhreddine D, et al
    Genome-wide multi-trait analysis of irritable bowel syndrome and related mental conditions identifies 38 new independent variants.
    J Transl Med. 2023;21:272.
    PubMed    
    Abstract available

  28. LIU S, Huang Q, Huang Q, Wang Y, et al
    The protective effects of electroacupuncture on intestinal barrier lesions in IBS and UC model.
    Sci Rep. 2023;13:7276.
    PubMed    
    Abstract available

  29. RUAN X, Chen J, Sun Y, Zhang Y, et al
    Depression and 24 gastrointestinal diseases: a Mendelian randomization study.
    Transl Psychiatry. 2023;13:146.
    PubMed    
    Abstract available

  30. KE H, Li Z, Lin Q, Shen Z, et al
    Inflammatory bowel disease is causally related to irritable bowel syndrome: a bidirectional two-sample Mendelian randomization study.
    Front Med (Lausanne). 2023;10:1166683.
    PubMed    
    Abstract available

  31. OTANI K, Watanabe T, Takahashi K, Nadatani Y, et al
    Upper gastrointestinal endoscopic findings in functional constipation and irritable bowel syndrome diagnosed using the Rome IV criteria: a cross-sectional survey during a medical check-up in Japan.
    BMC Gastroenterol. 2023;23:140.
    PubMed    
    Abstract available

  32. ONANA NDONG P, Boutallaka H, Marine-Barjoan E, Ouizeman D, et al
    Prevalence of small intestinal bacterial overgrowth in irritable bowel syndrome (IBS): Correlating H(2) or CH(4) production with severity of IBS.
    JGH Open. 2023;7:311-320.
    PubMed    
    Abstract available

  33. RUSSO F, Riezzo G, Linsalata M, Orlando A, et al
    Corrigendum: Managing symptom profile of IBS-D patients with Tritordeum-based foods: results from a pilot study.
    Front Nutr. 2023;10:1196030.
    PubMed    
    Abstract available

  34. A AJ, Suresh A
    Oral microbial shift induced by probiotic Bacillus coagualans along with its clinical perspectives.
    J Oral Biol Craniofac Res. 2023;13:398-402.
    PubMed    
    Abstract available

  35. PALANISAMY A, Sharma R, Singh PP, Sharma U, et al
    Shatavarin-IV saponin adjuvant elicits IgG and IgG2b responses against Staphylococcus aureus bacterin in a murine model.
    Heliyon. 2023;9:e15339.
    PubMed    
    Abstract available

  36. DIBAISE JK
    Short bowel syndrome: Recognizing unmet needs.
    Nutr Clin Pract. 2023;38 Suppl 1:S4-S8.
    PubMed    


  37. CLEMENTE T, Caccia R, Galli L, Galli A, et al
    Inflammation burden score in multidrug-resistant HIV-1 infection.
    J Infect. 2023;86:453-461.
    PubMed    
    Abstract available

  38. PAN X, Cong H, Wang X, Zhang H, et al
    Deep learning-extracted CT imaging phenotypes predict response to total resection in colorectal cancer.
    Acta Radiol. 2023;64:1783-1791.
    PubMed    
    Abstract available

  39. FUJIKAWA Y, Tominaga K
    Enhanced neuron-glia network in the submucosa and increased neuron outgrowth into the mucosa are associated with distinctive expressions of neuronal factors in the colon of rat IBS model.
    Neurogastroenterol Motil. 2023 May 12:e14595. doi: 10.1111/nmo.14595.
    PubMed    
    Abstract available

  40. CHEN X, Hu C, Yan C, Tao E, et al
    Maternal separation leads to dynamic changes of visceral hypersensitivity and fecal metabolomics from childhood to adulthood.
    Sci Rep. 2023;13:7670.
    PubMed    
    Abstract available

  41. GAUS OV, Livzan MA
    [Irritable bowel syndrome phenotypes: leading factors of genetics and epigenetics, mechanisms of formation].
    Ter Arkh. 2023;95:164-172.
    PubMed    
    Abstract available

  42. BAULO EV, Belostotsky NI, Akhmadullina OV, Dbar SR, et al
    [The effect of the FODMAP and rebamipid diet on the activity of disaccharidases in patients with enteropathy with impaired membrane digestion].
    Ter Arkh. 2023;95:140-144.
    PubMed    
    Abstract available

  43. MAEV IV, Okhlobystina OZ, Khalif IL, Andreev DN, et al
    [Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study].
    Ter Arkh. 2023;95:38-51.
    PubMed    
    Abstract available

  44. COCETTA V, Giacomini I, Tinazzi M, Berretta M, et al
    Maintenance of intestinal epithelial barrier integrity by a combination of probiotics, herbal extract, and vitamins.
    Minerva Pediatr (Torino). 2023 May 11. doi: 10.23736/S2724-5276.23.07128.
    PubMed    
    Abstract available

  45. ABEDI A, Kohli P, Montero S, Morales L, et al
    Content, face, and construct validity of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) as a measure of bowel-related quality of life in spinal cord injury.
    Neurourol Urodyn. 2023 May 11. doi: 10.1002/nau.25201.
    PubMed    
    Abstract available

  46. MOHAMMADI EN, Ligon CO, Mackenzie KD, Stratton J, et al
    ANTINOCICEPTIVE EFFECTS OF AN ANTI-CGRP ANTIBODY IN RAT MODELS OF COLON-BLADDER CROSS ORGAN SENSITIZATION.
    J Pharmacol Exp Ther. 2023 May 10:JPET-AR-2022-001480.
    PubMed    
    Abstract available

  47. KAUR CP, Yong CC, Rajamanikam A, Samudi C, et al
    The role and influence of bacteria on the growth of Blastocystis sp. subtype 3.
    Parasitol Res. 2023 May 10. doi: 10.1007/s00436-023-07842.
    PubMed    
    Abstract available

  48. WIKLENDT L, Mohd Rosli R, Kumar R, Paskaranandavadivel N, et al
    Inhibited postprandial retrograde cyclic motor pattern in the distal colon of patients with diarrhea predominant irritable bowel syndrome.
    Am J Physiol Gastrointest Liver Physiol. 2023.
    PubMed    
    Abstract available

  49. OHLMANN H, Lanters LR, Theysohn N, Langhorst J, et al
    Distinct alterations in central pain processing of visceral and somatic pain in quiescent ulcerative colitis compared to irritable bowel syndrome and health.
    J Crohns Colitis. 2023 May 10:jjad080. doi: 10.1093.
    PubMed    
    Abstract available

  50. FALLETTO E, Martellucci J, Rossitti P, Bondurri A, et al
    Transanal irrigation in functional bowel disorders and LARS: short-term results from an Italian national study.
    Tech Coloproctol. 2023;27:481-490.
    PubMed    
    Abstract available

  51. GERARDA GRAVINA A, Pellegrino R, Romeo M, Palladino G, et al
    The Burden of Irritable Bowel Syndrome in Medical and Nurse Italian University Student Population: The VANVITELLI-IBS Survey.
    Rev Recent Clin Trials. 2023 May 8. doi: 10.2174/1574887118666230508154027.
    PubMed    
    Abstract available

  52. GANZEVOORT IN, Fokkema T, Mol-Alma HJ, Heida A, et al
    Home-based guided hypnotherapy for children with functional abdominal pain and irritable bowel syndrome in primary care: study protocol for a randomised controlled trial.
    BMJ Open. 2023;13:e069653.
    PubMed    
    Abstract available

  53. JEONG B, Song YP, Chung JY, Park KC, et al
    Low concentrations of tricyclic antidepressants stimulate TRPC4 channel activity by acting as an opioid receptor ligand.
    Am J Physiol Cell Physiol. 2023 May 8. doi: 10.1152/ajpcell.00535.2022.
    PubMed    
    Abstract available

  54. GAYOSO L, Garcia-Etxebarria K, Arzallus T, Montalvo I, et al
    The effect of starch- and sucrose-reduced diet accompanied by nutritional and culinary recommendations on the symptoms of irritable bowel syndrome patients with diarrhoea.
    Therap Adv Gastroenterol. 2023;16:17562848231156682.
    PubMed    
    Abstract available

  55. MAAS GENANNT BERMPOHL F, Hulsmann L, Martin A
    Efficacy of mindfulness- and acceptance-based cognitive-behavioral therapies for bodily distress in adults: a meta-analysis.
    Front Psychiatry. 2023;14:1160908.
    PubMed    
    Abstract available

  56. SEELING KS, Hehl L, Vell MS, Rendel MD, et al
    Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome-wide association study.
    United European Gastroenterol J. 2023 May 7. doi: 10.1002/ueg2.12397.
    PubMed    
    Abstract available

  57. TUCKER MDR, Noga MHL, Lee DC, Chiu MDS, et al
    Pelvic Pain Comorbidities Associated with Quality-of-life after Endometriosis Surgery.
    Am J Obstet Gynecol. 2023 May 4:S0002-9378(23)00278.
    PubMed    
    Abstract available

  58. MENGZHU S, Yujie Z, Yafang S, Jing G, et al
    Electroacupuncture alleviates water avoidance stress-induced irritable bowel syndrome in mice by improving intestinal barrier functions and suppressing the expression of inflammatory cytokines.
    J Tradit Chin Med. 2023;43:494-500.
    PubMed    
    Abstract available

  59. GABRIELSSON A, Tromans S, Watkins L, Burrows L, et al
    Poo Matters! A scoping review of impact of constipation on epilepsy.
    Seizure. 2023;108:127-136.
    PubMed    
    Abstract available

  60. BISCHOFF SC, Ockenga J, Eshraghian A, Barazzoni R, et al
    Practical guideline on obesity care in patients with gastrointestinal and liver diseases - Joint ESPEN/UEG guideline.
    Clin Nutr. 2023;42:987-1024.
    PubMed    
    Abstract available

  61. TIAN D, Yan HJ, Huang H, Zuo YJ, et al
    Machine Learning-Based Prognostic Model for Patients After Lung Transplantation.
    JAMA Netw Open. 2023;6:e2312022.
    PubMed    
    Abstract available

  62. STRIBLING P, Ibrahim F
    Dietary fibre definition revisited - The case of low molecular weight carbohydrates.
    Clin Nutr ESPEN. 2023;55:340-356.
    PubMed    
    Abstract available

  63. TIAN S, Zhang H, Chen S, Wu P, et al
    Global research progress of visceral hypersensitivity and irritable bowel syndrome: bibliometrics and visualized analysis.
    Front Pharmacol. 2023;14:1175057.
    PubMed    
    Abstract available

  64. CHUAH KH, Hian WX, Lim SZ, Beh KH, et al
    Impact of Small Intestinal Bacterial Overgrowth on Symptoms and Quality of Life in Irritable Bowel Syndrome.
    J Dig Dis. 2023 May 18. doi: 10.1111/1751-2980.13189.
    PubMed    
    Abstract available

  65. VISWANATHAN L, Rao SS
    Intestinal Disaccharidase Deficiency in Adults: Evaluation and Treatment.
    Curr Gastroenterol Rep. 2023 May 18. doi: 10.1007/s11894-023-00870.
    PubMed    
    Abstract available

  66. SMILIOTOPOULOS T, Zampelas A, Houliaras G, Sgouros SN, et al
    Association of fructose consumption with prevalence of Functional Gastrointestinal Disorders (FGIDs) manifestations: Results from Hellenic National Nutrition and Health Survey (HNNHS).
    Br J Nutr. 2023 May 18:1-33. doi: 10.1017/S0007114523001198.
    PubMed    
    Abstract available

  67. GALICA AN, Grabocka E, Dumitrascu DL
    Is C-section a risk factor for the early onset of irritable bowel syndrome?
    Med Pharm Rep. 2023;96:164-169.
    PubMed    
    Abstract available

  68. WEN Y, Wang X, Si K, Xu L, et al
    Exploring the mechanisms of self-made Kuiyu Pingchang recipe for the treatment of ulcerative colitis and irritable bowel syndrome using a network pharmacology-based approach and molecular docking.
    Curr Comput Aided Drug Des. 2023 May 15. doi: 10.2174/1573409919666230515103224.
    PubMed    
    Abstract available

  69. ZHAO C, Zhou X, Shi X
    The influence of Nav1.9 channels on intestinal hyperpathia and dysmotility.
    Channels (Austin). 2023;17:2212350.
    PubMed    
    Abstract available

  70. FU YM, Liang FX, Li J, Wu S, et al
    [Mechanism of acupuncture-moxibustion with "Biao-Ben" acupoint combination in treating irritable bowel syndrome rats by regulating serum metabolites and metabolic pathway based on TM widely targeted metabolomics method].
    Zhen Ci Yan Jiu. 2023;48:339-46.
    PubMed    
    Abstract available

  71. CHEN D, Zhang Y, Huang T, Jia J, et al
    Depression and risk of gastrointestinal disorders: a comprehensive two-sample Mendelian randomization study of European ancestry.
    Psychol Med. 2023 May 15:1-13. doi: 10.1017/S0033291723000867.
    PubMed    
    Abstract available

  72. GARNAS E
    Fermented Vegetables as a Potential Treatment for Irritable Bowel Syndrome.
    Curr Dev Nutr. 2023;7:100039.
    PubMed    
    Abstract available

  73. ABDALLA E, Mohymeed N, Nail AMA, Tonga RA, et al
    Protein-losing enteropathy as the first presentation of systemic lupus erythematosus: A case report from Sudan.
    Clin Case Rep. 2023;11:e7314.
    PubMed    
    Abstract available

  74. FETTUCCIARI K, Fruganti A, Stracci F, Spaterna A, et al
    Clostridioides difficile Toxin B Induced Senescence: A New Pathologic Player for Colorectal Cancer?
    Int J Mol Sci. 2023;24:8155.
    PubMed    
    Abstract available

  75. MERECZ K, Hirsa M, Biniszewska O, Fichna J, et al
    An overview of 5-HT(3) receptor antagonists as a treatment option for irritable bowel syndrome with diarrhea.
    Expert Opin Pharmacother. 2023 May 12. doi: 10.1080/14656566.2023.2214314.
    PubMed    
    Abstract available

  76. LIU B, Ye D, Yang H, Song J, et al
    Assessing the relationship between gut microbiota and irritable bowel syndrome: a two-sample Mendelian randomization analysis.
    BMC Gastroenterol. 2023;23:150.
    PubMed    
    Abstract available

  77. SANCHEZ-ROIGE S, Jennings MV, Thorpe HHA, Mallari JE, et al
    CADM2 is implicated in impulsive personality and numerous other traits by genome- and phenome-wide association studies in humans and mice.
    Transl Psychiatry. 2023;13:167.
    PubMed    
    Abstract available

  78. PERRY D, Moe SS, Thomas B, Lindblad AJ, et al
    Top studies of 2022 relevant to primary care: From the PEER team.
    Can Fam Physician. 2023;69:325-329.
    PubMed    
    Abstract available

  79. XIE A, Zhao S, Liu Z, Yue X, et al
    Polysaccharides, proteins, and their complex as microencapsulation carriers for delivery of probiotics: A review on carrier types and encapsulation techniques.
    Int J Biol Macromol. 2023;242.
    PubMed    
    Abstract available

  80. GHOSHAL UC, Ghoshal U, Shah A, Holtmann G, et al
    Evaluation of small intestinal bacterial overgrowth.
    Expert Rev Gastroenterol Hepatol. 2023;17:461-467.
    PubMed    
    Abstract available

  81. EIDSTO E, Selinheimo S, Lampi J, Salmela A, et al
    The continuum of severity of functional impairment due to indoor air symptoms: prevalence and determinants.
    J Occup Environ Med. 2023 May 24. doi: 10.1097/JOM.0000000000002884.
    PubMed    
    Abstract available

  82. BEERTEN SG, Coteur K, Mamouris P, Van Nuland M, et al
    Trends in the registration of anxiety in Belgian primary care from 2000 to 2021: a registry-based study.
    Br J Gen Pract. 2023;73:e460-e467.
    PubMed    
    Abstract available

  83. UKHANOVA M, Voss RW, Marino M, Huguet N, et al
    Chronic overlapping pain conditions and long-term opioid treatment.
    Am J Manag Care. 2023;29:233-239.
    PubMed    
    Abstract available

  84. ZHOU S, Luo H, Tian Y, Li H, et al
    Investigating the shared genetic architecture of post-traumatic stress disorder and gastrointestinal tract disorders: a genome-wide cross-trait analysis.
    Psychol Med. 2023 May 23:1-9. doi: 10.1017/S0033291723001423.
    PubMed    
    Abstract available

  85. GOODOORY VC, Tuteja AK, Black CJ, Ford AC, et al
    Letter: Efficacy of Mesalamine in Irritable Bowel Syndrome - Authors' reply.
    Clin Gastroenterol Hepatol. 2023 May 20:S1542-3565(23)00381.
    PubMed    


  86. YU XL, Wu QQ, He LP, Zheng YF, et al
    Role of in vitamin D in irritable bowel syndrome.
    World J Clin Cases. 2023;11:2677-2683.
    PubMed    
    Abstract available

  87. JIN X, Hu Y, Lin T, Gao F, et al
    Selenium-enriched Bifidobacterium longum DD98 relieves irritable bowel syndrome induced by chronic unpredictable mild stress in mice.
    Food Funct. 2023 May 22. doi: 10.1039/d2fo03408.
    PubMed    
    Abstract available

  88. ZHANG X, Xu W, Zhong W, Zhang W, et al
    Exploring the links between gut microbiome changes and irritable bowel syndrome in Han populations in the Tibetan Plateau.
    J Zhejiang Univ Sci B. 2023 May 19:1-16. doi: 10.1631/jzus.B2200509.
    PubMed    
    Abstract available

  89. BAI X, Sun X, Yu Y, Guo Y, et al
    Immobilization of alpha-galactosidase in polyvinyl alcohol-chitosan-glycidyl methacrylate hydrogels based on directional freezing-assisted salting-out strategy for hydrolysis of RFOs.
    Int J Biol Macromol. 2023 May 19:124808. doi: 10.1016/j.ijbiomac.2023.124808.
    PubMed    
    Abstract available

  90. GOODOORY VC, Guthrie EA, Ng CE, Black CJ, et al
    Letter: Does irritable bowel syndrome have a greater impact in Western, compared with Asian, patients? Authors' reply.
    Aliment Pharmacol Ther. 2023;57:1190-1191.
    PubMed    


  91. GOODOORY VC, Ng CE, Black CJ, Ford AC, et al
    Editorial: faecal incontinence is prevalent in IBS, as are effective treatment options! Authors' reply.
    Aliment Pharmacol Ther. 2023;57:1176-1177.
    PubMed    


  92. SHARMA A, Rao S
    Editorial: faecal incontinence is prevalent in IBS, as are effective treatment options!
    Aliment Pharmacol Ther. 2023;57:1174-1175.
    PubMed    


  93. CHUAH KH, Mahadeva S
    Letter: Does irritable bowel syndrome have a greater impact in Western, compared with Asian, patients?
    Aliment Pharmacol Ther. 2023;57:1188-1189.
    PubMed    


  94. GUNN D, Ford A, Farrin A, Spiller R, et al
    Editorial: ondansetron for patients with IBS-D and bowel-predominant symptoms-authors' reply.
    Aliment Pharmacol Ther. 2023;57:1337-1338.
    PubMed    


  95. SHAH ED
    Editorial: ondansetron for patients with IBS-D and bowel-predominant symptoms.
    Aliment Pharmacol Ther. 2023;57:1335-1336.
    PubMed    


  96. KHAN Z
    Continuing Medical Education Questions: May 2023.
    Am J Gastroenterol. 2023;118:779.
    PubMed    
    Abstract available

  97. PURTLE BJ, Cash BD
    In persons with constipation or IBS-C, kiwifruit vs. psyllium increased spontaneous bowel movements.
    Ann Intern Med. 2023;176:JC53.
    PubMed    
    Abstract available

  98. KUANG R, Levinthal DJ, Ghaffari AA, Del Aguila de Rivers CR, et al
    Nightshade Vegetables: A Dietary Trigger for Worsening Inflammatory Bowel Disease and Irritable Bowel Syndrome?
    Dig Dis Sci. 2023 May 19. doi: 10.1007/s10620-023-07955.
    PubMed    
    Abstract available

  99. GOODOORY VC, Ford AC
    Antibiotics and Probiotics for Irritable Bowel Syndrome.
    Drugs. 2023 May 15. doi: 10.1007/s40265-023-01871.
    PubMed    
    Abstract available

  100. YAMAMOTO Y, Furukawa S, Miyake T, Watanabe J, et al
    Exercise habits that include exercise partners and irritable bowel syndrome in a young Japanese population: a cross-sectional study.
    Eur J Gastroenterol Hepatol. 2023 Apr 17. doi: 10.1097/MEG.0000000000002561.
    PubMed    
    Abstract available

  101. HREINSSON JP, Tornblom H, Tack J, Drossman DA, et al
    Factor Analysis of the Rome IV Criteria for Major Disorders of Gut-Brain Interaction (DGBI) Globally and Across Geographical, Sex, and Age Groups.
    Gastroenterology. 2023;164:1211-1222.
    PubMed    
    Abstract available

  102. FOGELSON KA, Dorrestein PC, Zarrinpar A, Knight R, et al
    The Gut Microbial Bile Acid Modulation and its Relevance to Digestive Health and Diseases.
    Gastroenterology. 2023 Feb 23:S0016-5085(23)00161.
    PubMed    
    Abstract available

  103. ANDERSSON OP
    Is the microbiome the cause of irritable bowel syndrome and inflammatory bowel disease? Lessons to consider from odontology.
    Int J Colorectal Dis. 2023;38:117.
    PubMed    
    Abstract available

  104. BRENNER DM, Dominguez-Munoz JE
    Differential Diagnosis of Chronic Diarrhea: An Algorithm to Distinguish Irritable Bowel Syndrome With Diarrhea From Other Organic Gastrointestinal Diseases, With Special Focus on Exocrine Pancreatic Insufficiency.
    J Clin Gastroenterol. 2023 Apr 27. doi: 10.1097/MCG.0000000000001855.
    PubMed    
    Abstract available

  105. DOTHEL G, Barbaro MR, Di Vito A, Ravegnini G, et al
    New insights into irritable bowel syndrome pathophysiological mechanisms: contribution of epigenetics.
    J Gastroenterol. 2023 May 9. doi: 10.1007/s00535-023-01997.
    PubMed    
    Abstract available

  106. VARNI JW, Chumpitazi BP, Febo-Rodriguez L, Shulman RJ, et al
    Gastrointestinal Symptoms Profile in Gastroparesis Compared to OtherFunctional and Organic Gastrointestinal Diseases.
    J Pediatr Gastroenterol Nutr. 2023 Apr 25. doi: 10.1097/MPG.0000000000003806.
    PubMed    
    Abstract available

  107. VAN TILBURG MAL, Reed B, Benninga M, Chogle A, et al
    Letter RE: Efficacy of oral psyllium in pediatric Irritable Bowel Syndrome: A double-blind randomized control trial.
    J Pediatr Gastroenterol Nutr. 2023 Apr 26. doi: 10.1097/MPG.0000000000003814.
    PubMed    


  108. MENON J, Puttiah SK
    Response to letter RE: Severity Assessment Scores For Irritable Bowel Syndrome In Children: Are We There Yet?
    J Pediatr Gastroenterol Nutr. 2023 Apr 26. doi: 10.1097/MPG.0000000000003813.
    PubMed    



  109. Functional Gastrointestinal Disorders in Mediterranean Countries According to Rome IV Criteria: Erratum.
    J Pediatr Gastroenterol Nutr. 2023;76:695.
    PubMed    


  110. WANG C, Yin Y, Wang L, Guo X, et al
    Association between Helicobacter pylori infection and irritable bowel syndrome: a systematic review and meta-analysis.
    Postgrad Med J. 2023;99:166-175.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.


;